600750 江中药业
已收盘 11-04 15:00:00
资讯
新帖
简况
券商密集调仓换股,三季度重仓哪些股票?
《投资有道》杂志 · 10-31
券商密集调仓换股,三季度重仓哪些股票?
【机构调研记录】易米基金调研健康元、江中药业等3只个股(附名单)
证券之星 · 10-30
【机构调研记录】易米基金调研健康元、江中药业等3只个股(附名单)
【机构调研记录】恒生前海基金调研特宝生物、江中药业等5只个股(附名单)
证券之星 · 10-30
【机构调研记录】恒生前海基金调研特宝生物、江中药业等5只个股(附名单)
江中药业:10月28日召开分析师会议,包括知名机构明汯投资,正圆投资的多家机构参与
证券之星 · 10-29
江中药业:10月28日召开分析师会议,包括知名机构明汯投资,正圆投资的多家机构参与
江中药业回应健胃消食片价格差异:主要为终端自发行为,“四同”政策预计影响不大
财经网 · 10-28
江中药业回应健胃消食片价格差异:主要为终端自发行为,“四同”政策预计影响不大
江中药业:前三季度营收减少8.19%至29.72亿,处方药类由于部分产品集采未中标收入下滑25.1%
财经网 · 10-28
江中药业:前三季度营收减少8.19%至29.72亿,处方药类由于部分产品集采未中标收入下滑25.1%
江中药业前三季净利超6亿,拟8600万购买江中饮片51%股权
新京报网 · 10-25
江中药业前三季净利超6亿,拟8600万购买江中饮片51%股权
江中药业(600750.SH)发前三季业绩,净利润6.34亿元,同比增长7.09%
智通财经 · 10-25
江中药业(600750.SH)发前三季业绩,净利润6.34亿元,同比增长7.09%
华润医药:江中药业前三季度实现净利润6.84亿元,同比增长8.98%
智通财经 · 10-25
华润医药:江中药业前三季度实现净利润6.84亿元,同比增长8.98%
华润医药(03320):江中药业前三季度实现净利润6.84亿元,同比增长8.98%
智通财经 · 10-25
华润医药(03320):江中药业前三季度实现净利润6.84亿元,同比增长8.98%
江中药业最新公告:拟8612.38万元购买江中饮片51%股权
证券之星 · 10-25
江中药业最新公告:拟8612.38万元购买江中饮片51%股权
江中药业最新公告:第三季度净利润同比增2.15%
证券之星 · 10-25
江中药业最新公告:第三季度净利润同比增2.15%
江中药业:第三季度净利润同比增2.15%
美港电讯 · 10-25
江中药业:第三季度净利润同比增2.15%
江中药业10月22日主力资金流入175万元 连续3日加仓
市场透视 · 10-22
江中药业10月22日主力资金流入175万元 连续3日加仓
【港股通】华润医药(03320)附属拟至多1.2亿人币增持江中药业
金吾财讯 · 10-22
【港股通】华润医药(03320)附属拟至多1.2亿人币增持江中药业
华润医药(03320.HK)附属江中药业控股股东拟最多1.2亿人民币增持
阿斯达克财经 · 10-21
华润医药(03320.HK)附属江中药业控股股东拟最多1.2亿人民币增持
华润医药(03320):华润江中拟增持江中药业股份 增持总金额为0.6亿元-1.2亿元
智通财经 · 10-21
华润医药(03320):华润江中拟增持江中药业股份 增持总金额为0.6亿元-1.2亿元
江中药业(600750.SH)控股股东拟斥0.6亿元至1.2亿元增持股份
智通财经 · 10-21
江中药业(600750.SH)控股股东拟斥0.6亿元至1.2亿元增持股份
江中药业:控股股东拟6000万元—1.2亿元增持公司股份
美港电讯 · 10-21
江中药业:控股股东拟6000万元—1.2亿元增持公司股份
江中药业最新公告:控股股东华润江中拟6000万元-1.2亿元增持公司股份
证券之星 · 10-21
江中药业最新公告:控股股东华润江中拟6000万元-1.2亿元增持公司股份
加载更多
公司概况
公司名称:
江中药业股份有限公司
所属行业:
医药制造业
上市日期:
1996-09-23
主营业务:
江中药业股份有限公司是一家属江西省医药行业类的公司。主营业务是药品和大健康产品的生产、研发与销售。公司主要产品是非处方药、处方药、大健康产品及其他。公司拥有“江中”“初元”两个中国驰名商标和“桑海”“杨济生”两个江西省著名商标。其中“江中”品牌连续20年荣登世界品牌实验室“中国500最具价值品牌”榜,品牌价值376.29亿元,位于医药行业第6位。江中牌健胃消食片已连续十九年蝉联中国非处方药产品综合统计排名中成药消化类第一名,荣膺2022年度中国非处方药黄金大单品,荣获2023年金鼠标国际数字营销节“跨界联合营销·金奖”,凭借美食跨界创新营销荣获2023年乌镇健康大会“西湖奖·创新营销案例”。江中利活牌乳酸菌素片荣获2022年中国药店“店员推荐率最高品牌”、2023年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”、2023年中国肠道大会“年度后生元先锋品牌”、第四届医药金石奖“2023年度最佳医药营销创新奖”,荣登2023年美思会“中国医药·品牌榜”。公司以“制造文明”为核心,坚持精益生产和智能制造,持续强化节能减排,有序推动碳达峰、碳中和工作,为中医药行业节能标准化提供了可复制、可推广的先进经验。公司先后获得“中国生态文明奖先进集体”“中华环境优秀奖”“香港优越环保管理金奖”,以及国家工信部“中药提取智能制造新模式项目”、国家级“节能标准化示范项目”。江中牌健胃消食片已连续二十年获中国非处方药产品综合排名中成药消化品类第一名,并荣获2023-2024年度中国药品零售市场畅销品牌、2024大健康产业“产品引领奖”等荣誉;江中利活牌乳酸菌素片荣获2023-2024年度中国药品零售市场畅销品牌、2024年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”等荣誉。
发行价格:
6.80
{"stockData":{"symbol":"600750","market":"SH","secType":"STK","nameCN":"江中药业","latestPrice":21.19,"timestamp":1730703600000,"preClose":20.89,"halted":0,"volume":7670750,"delay":0,"floatShares":626000000,"shares":629000000,"eps":1.1972,"marketStatus":"已收盘","marketStatusCode":5,"change":0.3,"latestTime":"11-04 15:00:00","open":20.99,"high":21.41,"low":20.92,"amount":162000000,"amplitude":0.0235,"askPrice":21.2,"askSize":149,"bidPrice":21.19,"bidSize":157,"shortable":0,"etf":0,"ttmEps":1.1972,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730770200000},"adr":0,"adjPreClose":20.89,"symbolType":"stock","openAndCloseTimeList":[[1730683800000,1730691000000],[1730696400000,1730703600000]],"highLimit":22.98,"lowLimit":18.8,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":629128757,"pbRate":3.59,"roa":"--","roe":"16.03%","epsLYR":1.12,"committee":0.480535,"marketValue":13331000000,"floatMarketCap":13256000000,"peRate":17.699633,"changeRate":0.0144,"turnoverRate":0.0123,"status":0},"requestUrl":"/m/hq/s/600750","defaultTab":"news","newsList":[{"id":"2479774460","title":"券商密集调仓换股,三季度重仓哪些股票?","url":"https://stock-news.laohu8.com/highlight/detail?id=2479774460","media":"《投资有道》杂志","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479774460?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:11","pubTimestamp":1730365860,"startTime":"0","endTime":"0","summary":"券商密集调仓换股据Choice金融终端数据,截至10月29日,约4055家A股上市公司已披露三季报,其中约264家上市公司的前十大流通股股东中包含券商。除获券商增持外,江中药业三季度也获外资、社保基金增持,分别增持1.64%和0.41%。此外,国光电器高度重视VR相关业务,已成为国内外主要头部VR企业的声学模组供应商,并为多家头部企业稳定供货。创世纪2024年前三季度实现营业收入32.76亿元,同比增长17.59%;实现归属净利润2.02亿元,同比增长24.35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2024-10-31/doc-incumwne2918764.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-10-31/doc-incumwne2918764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301262","LU0405327148.USD","002736","301566","LU1979443071.USD","LU1997245177.USD","601688","601881","BK0175","600999","BK0010","BK0077","BK0155","BK0189","301191","300722","BK0279","LU1997245094.SGD","000776","LU1064130708.USD","LU1781817850.SGD","600750","301180","LU1997244956.HKD","301314","300440","301125","601066","688216","BK0108","000166","LU2289578879.USD","BK0026","LU2148510915.USD","301357","603261","601995","LU1064131003.USD","301141","300493","BK0028","300083","600030","601211","159982","301318","399300","002045","BK0183","BK0231"],"gpt_icon":0},{"id":"2479744298","title":"【机构调研记录】易米基金调研健康元、江中药业等3只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479744298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479744298?lang=zh_cn&edition=full","pubTime":"2024-10-30 08:05","pubTimestamp":1730246740,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月29日披露的机构调研信息,易米基金近期对3家上市公司进行了调研,相关名单如下:1)健康元 个股亮点:公司GDR已经于2022-09-26成功上市。旗下最近一年表现最佳的公募基金产品为易米中证科创创业50指数增强发起A,最新单位净值为0.95,近一年增长13.3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000009102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0028","BK0114","BK0175","BK0239","BK0046","BK0188","600380","BK0077"],"gpt_icon":0},{"id":"2479229874","title":"【机构调研记录】恒生前海基金调研特宝生物、江中药业等5只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2479229874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479229874?lang=zh_cn&edition=full","pubTime":"2024-10-30 08:05","pubTimestamp":1730246727,"startTime":"0","endTime":"0","summary":"4)天宇股份 个股亮点:主营为化学原料药及中间体的研发、生产和销售,按照业务类型可分为原料药及中间体的非CMO业务和原料药及中间体的CMO业务,产品主要包括抗高血压药物原料药及中间体、抗哮喘药物原料药及中间体、抗病毒药物中间体;公司合成生物学的技术平台正在建设中,目前已与高校达成合作共同开展生物催化相关研究。旗下最近一年表现最佳的公募基金产品为恒生前海港股通高股息指数,最新单位净值为0.94,近一年增长23.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000009092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0175","688278","600750","BK0239"],"gpt_icon":0},{"id":"2479475508","title":"江中药业:10月28日召开分析师会议,包括知名机构明汯投资,正圆投资的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2479475508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479475508?lang=zh_cn&edition=full","pubTime":"2024-10-29 17:42","pubTimestamp":1730194971,"startTime":"0","endTime":"0","summary":"江中药业2024年三季报显示,公司主营收入29.72亿元,同比下降8.19%;归母净利润6.34亿元,同比上升7.09%;扣非净利润6.16亿元,同比上升9.52%;其中2024年第三季度,公司单季度主营收入7.99亿元,同比下降8.64%;单季度归母净利润1.46亿元,同比上升2.15%;单季度扣非净利润1.44亿元,同比下降0.64%;负债率30.93%,投资收","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900033947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0188","BK0028","BK0239","BK0175"],"gpt_icon":0},{"id":"2478887121","title":"江中药业回应健胃消食片价格差异:主要为终端自发行为,“四同”政策预计影响不大","url":"https://stock-news.laohu8.com/highlight/detail?id=2478887121","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478887121?lang=zh_cn&edition=full","pubTime":"2024-10-28 14:55","pubTimestamp":1730098526,"startTime":"0","endTime":"0","summary":"10月28日,江中药业举办2024年第三季度业绩说明会。未来,公司将保持相对稳定持续的分红政策。还有投资者询问,江中健胃消食片在各地区价格差异大,下一步“四同”整治将对公司利润带来多大影响。管理层在回应中提到,部分地区零售终端价格存在一定差异,主要为终端自发行为,“四同”政策预计对公司产品的影响不大。处方药板块将积极融入行业新格局,强化合规发展和运营质量提升,多措并举实现高质量发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028150529a1f0ec53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028150529a1f0ec53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","BK0188","BK0028","600750","BK0239"],"gpt_icon":0},{"id":"2478140891","title":"江中药业:前三季度营收减少8.19%至29.72亿,处方药类由于部分产品集采未中标收入下滑25.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478140891","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478140891?lang=zh_cn&edition=full","pubTime":"2024-10-28 09:34","pubTimestamp":1730079243,"startTime":"0","endTime":"0","summary":"近日,江中药业发布2024年前三季度财报。披露公司前三季度营收下滑8.19%至29.72亿元,归属净利增长7.09%至6.34亿元。第三季度单季营收降低8.64%至7.99亿元,归属净利增加2.15%至1.46亿元。分行业看,医药工业收入降低8.35%至29.41亿元,酒类收入下滑8.71%至746.05万元。分产品看,非处方药类收入增长2.78%至23.35亿元,处方药类收入下滑25.1%至3.65亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028093612a1f02049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028093612a1f02049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600750"],"gpt_icon":0},{"id":"2478322559","title":"江中药业前三季净利超6亿,拟8600万购买江中饮片51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2478322559","media":"新京报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478322559?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:58","pubTimestamp":1729868280,"startTime":"0","endTime":"0","summary":"今年前三季度,公司实现营业收入29.72亿元,同比下降8.19%;归属于上市公司股东的净利润6.34亿元,同比增长7.09%。其中,第三季度实现营业收入7.99亿元,同比下降8.64%。同日,江中药业公告宣布,以自有资金8612.38万元购买华润江中制药集团有限责任公司所持有的江西江中中药饮片有限公司51%股权。江中药业称,本次交易有利于公司探索布局中医药上游资源,完善中药产业链建设,减少关联交易。2024前三季度营业收入预计增加1.52亿元,净利润预计增加1736万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025225934a1eaba53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025225934a1eaba53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600750","BK0028","BK0188","BK0239","BK0175"],"gpt_icon":0},{"id":"2478693897","title":"江中药业(600750.SH)发前三季业绩,净利润6.34亿元,同比增长7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478693897","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478693897?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:32","pubTimestamp":1729863168,"startTime":"0","endTime":"0","summary":"智通财经APP讯,江中药业(600750.SH)发布2024年前三季度报告,报告期内公司实现营业收入29.72亿元,同比减少8.19%;归属于上市公司股东的净利润6.34亿元,同比增长7.09%;归属于上市公司股东扣除非经常性损益净利润6.16亿元,同比增长9.52%;基本每股收益1.01元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600750"],"gpt_icon":0},{"id":"2478398136","title":"华润医药:江中药业前三季度实现净利润6.84亿元,同比增长8.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478398136","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478398136?lang=zh_cn&edition=full","pubTime":"2024-10-25 20:01","pubTimestamp":1729857703,"startTime":"0","endTime":"0","summary":"华润医药(03320)发布公告,于2024年10月25日,江中药业公布其截至2024年9月30日止九个月的季度报告,营业总收入29.72亿元(人民币,下同),同比减少8.19%;净利润6.84亿元,同比增长8.98%。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20241025/c662823896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["600750"],"gpt_icon":0},{"id":"2478989312","title":"华润医药(03320):江中药业前三季度实现净利润6.84亿元,同比增长8.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478989312","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478989312?lang=zh_cn&edition=full","pubTime":"2024-10-25 19:56","pubTimestamp":1729857383,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布公告,于2024年10月25日,江中药业公布其截至2024年9月30日止九个月的季度报告,营业总收入29.72亿元(人民币,下同),同比减少8.19%;净利润6.84亿元,同比增长8.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600750","03320"],"gpt_icon":0},{"id":"2478604013","title":"江中药业最新公告:拟8612.38万元购买江中饮片51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2478604013","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478604013?lang=zh_cn&edition=full","pubTime":"2024-10-25 18:19","pubTimestamp":1729851577,"startTime":"0","endTime":"0","summary":"江中药业公告,公司拟以8612.38万元购买华润江中所持有的江西江中中药饮片有限公司(简称“江中饮片”)51%股权。本次交易构成关联交易,未构成重大资产重组。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500034538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0028","BK0188","BK0239","BK0175"],"gpt_icon":0},{"id":"2478604028","title":"江中药业最新公告:第三季度净利润同比增2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478604028","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478604028?lang=zh_cn&edition=full","pubTime":"2024-10-25 18:19","pubTimestamp":1729851556,"startTime":"0","endTime":"0","summary":"江中药业公告,公司第三季度实现营业收入7.99亿元,同比下降8.64%;净利润1.46亿元,同比增长2.15%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500034536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750"],"gpt_icon":0},{"id":"2478046166","title":"江中药业:第三季度净利润同比增2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478046166","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478046166?lang=zh_cn&edition=full","pubTime":"2024-10-25 18:12","pubTimestamp":1729851166,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["600750","BK0239","BK0188","BK0175","BK0028"],"gpt_icon":0},{"id":"2477621803","title":"江中药业10月22日主力资金流入175万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2477621803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477621803?lang=zh_cn&edition=full","pubTime":"2024-10-22 15:17","pubTimestamp":1729581447,"startTime":"0","endTime":"0","summary":"10月22日, 江中药业股价涨2.46%,报收22.95元,成交金额2.87亿元,换手率2.01%,振幅4.29%,量比1.58。江中药业今日主力资金净流入175万元,连续3日净流入,上一交易日主力净流入1290万元,今日环比减少86.43%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为63.64%,平均涨幅为1.58%。该股近5个交易日上涨4.60%,主力资金累计净流入754万元;近20日主力资金累计净流入7743万元,其中净流入天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221520069f55c91d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410221520069f55c91d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600750","BK0188","BK0028","BK0239","BK0175"],"gpt_icon":0},{"id":"2477024840","title":"【港股通】华润医药(03320)附属拟至多1.2亿人币增持江中药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2477024840","media":"金吾财讯","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477024840?lang=zh_cn&edition=full","pubTime":"2024-10-22 08:59","pubTimestamp":1729558756,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华润医药(03320)公告,公司非全资附属华润江中制药集团拟于12个月内通过上海证券交易所增持江中药业(600750)股份,增持总金额不低于6000万元人民币及不超过1.2亿元人民币。华润江中目前持有江中药业约43.09%股权,为江中药业控股股东,而该集团实际控制江中药业约26.09%,并以附属公司形式入帐。至于增持计划不设定价格区间,将根据对江中药业股票价值判断及二级市场波动情况实施增持计划。华润江中拟通过自有资金或自筹资金增持江中药业A股,且承诺在增持计划实施期限内及法定期限内不减持所持江中药业股份。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200915/MTQ3MGYxNDE0OGI1OTUxMGM4OTJjZmIwYjlmNjI1MDU4NDg4OA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/MTQ3MGYxNDE0OGI1OTUxMGM4OTJjZmIwYjlmNjI1MDU4NDg4OA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946220","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600750","BK0188","HSCEI","BK0175","BK1191","HSTECH","BK0239","YANG","BK1570","BK0028","03320"],"gpt_icon":0},{"id":"2477861199","title":"华润医药(03320.HK)附属江中药业控股股东拟最多1.2亿人民币增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2477861199","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477861199?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:37","pubTimestamp":1729521420,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布,沪A附属江中药业控股股东华润江中拟即日起十二个月内,增持江中药业股份,总金额不低于6,000万人民币,不超过1.2亿人民币。目前,江中药业由公司非全资附属华润江中持股43.09%,集团实际制江中药业约26.09%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-21 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1389814/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0175","BK0188","BK0028","600750","03320","BK1570","BK1191","BK0239"],"gpt_icon":0},{"id":"2477383702","title":"华润医药(03320):华润江中拟增持江中药业股份 增持总金额为0.6亿元-1.2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477383702","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477383702?lang=zh_cn&edition=full","pubTime":"2024-10-21 18:21","pubTimestamp":1729506101,"startTime":"0","endTime":"0","summary":"(三)拟增持股份的数量及金额:总体增持金额不低于0.6亿元人民币(含),不超过1.2亿元人民币(含)。增持计划实施期间内,江中药业股票因筹划重大事项连续停牌10个交易日以上的,增持计划在股票复牌后顺延实施。(七)增持主体承诺:华润江中承诺在增持计划实施期限内及法定期限内不减持其所持有的江中药业股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1570","03320","BK0188","600750","BK0239","BK0028","BK0175","BK1191"],"gpt_icon":0},{"id":"2477349138","title":"江中药业(600750.SH)控股股东拟斥0.6亿元至1.2亿元增持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2477349138","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477349138?lang=zh_cn&edition=full","pubTime":"2024-10-21 17:50","pubTimestamp":1729504216,"startTime":"0","endTime":"0","summary":"智通财经APP讯,江中药业(600750.SH)公告,公司控股股东华润江中制药集团有限责任公司(简称“华润江中”)拟自本公告披露之日起12个月内通过上海证券交易所交易系统允许的方式(包括但不限于集中竞价、大宗交易等)增持公司股份,增持总金额不低于0.6亿元人民币(含),不超过1.2亿元人民币(含)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196840.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600750","BK0175","BK0188","BK0239","BK0028"],"gpt_icon":0},{"id":"2477831064","title":"江中药业:控股股东拟6000万元—1.2亿元增持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2477831064","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477831064?lang=zh_cn&edition=full","pubTime":"2024-10-21 17:42","pubTimestamp":1729503747,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1191","BK1574","01477","BK0239","BK0188","BK0175","600750","BK0028"],"gpt_icon":0},{"id":"2477348758","title":"江中药业最新公告:控股股东华润江中拟6000万元-1.2亿元增持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2477348758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477348758?lang=zh_cn&edition=full","pubTime":"2024-10-21 17:39","pubTimestamp":1729503567,"startTime":"0","endTime":"0","summary":"江中药业公告,控股股东华润江中拟自本公告披露之日起12个月内通过上海证券交易所交易系统允许的方式增持公司股份,增持总金额不低于0.6亿元,不超过1.2亿元。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102100023563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600750","BK0188","BK0175","BK0239","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-09-23","address":"江西省南昌市青山湖区高新区火炬大道788号","stockEarnings":[{"period":"1week","weight":-0.0485},{"period":"1month","weight":-0.082},{"period":"3month","weight":-0.0456},{"period":"6month","weight":-0.1696},{"period":"1year","weight":0.1563},{"period":"ytd","weight":0.0658}],"companyName":"江中药业股份有限公司","boardCode":"AI0027","perCapita":"16343股","boardName":"医药制造业","registeredCapital":"62912万元","compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0079},{"period":"3month","weight":0.1545},{"period":"6month","weight":0.0581},{"period":"1year","weight":0.0922},{"period":"ytd","weight":0.1127}],"survey":" 江中药业股份有限公司是一家属江西省医药行业类的公司。主营业务是药品和大健康产品的生产、研发与销售。公司主要产品是非处方药、处方药、大健康产品及其他。公司拥有“江中”“初元”两个中国驰名商标和“桑海”“杨济生”两个江西省著名商标。其中“江中”品牌连续20年荣登世界品牌实验室“中国500最具价值品牌”榜,品牌价值376.29亿元,位于医药行业第6位。江中牌健胃消食片已连续十九年蝉联中国非处方药产品综合统计排名中成药消化类第一名,荣膺2022年度中国非处方药黄金大单品,荣获2023年金鼠标国际数字营销节“跨界联合营销·金奖”,凭借美食跨界创新营销荣获2023年乌镇健康大会“西湖奖·创新营销案例”。江中利活牌乳酸菌素片荣获2022年中国药店“店员推荐率最高品牌”、2023年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”、2023年中国肠道大会“年度后生元先锋品牌”、第四届医药金石奖“2023年度最佳医药营销创新奖”,荣登2023年美思会“中国医药·品牌榜”。公司以“制造文明”为核心,坚持精益生产和智能制造,持续强化节能减排,有序推动碳达峰、碳中和工作,为中医药行业节能标准化提供了可复制、可推广的先进经验。公司先后获得“中国生态文明奖先进集体”“中华环境优秀奖”“香港优越环保管理金奖”,以及国家工信部“中药提取智能制造新模式项目”、国家级“节能标准化示范项目”。江中牌健胃消食片已连续二十年获中国非处方药产品综合排名中成药消化品类第一名,并荣获2023-2024年度中国药品零售市场畅销品牌、2024大健康产业“产品引领奖”等荣誉;江中利活牌乳酸菌素片荣获2023-2024年度中国药品零售市场畅销品牌、2024年乌镇健康大会“西湖奖·最受药店欢迎的明星单品”等荣誉。","serverTime":1730755503016,"listedPrice":6.8,"stockholders":"38276人(较上一季度增加9.19%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"江中药业(600750)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供江中药业(600750)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"江中药业,600750,江中药业股票,江中药业股票老虎,江中药业股票老虎国际,江中药业行情,江中药业股票行情,江中药业股价,江中药业股市,江中药业股票价格,江中药业股票交易,江中药业股票购买,江中药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"江中药业(600750)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供江中药业(600750)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}